Clinical Trial Update: Efficacy of MND-2119 in Participants With Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy of MND-2119 in participants with hypertriglyceridemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• MND-2119

Snippet

Sponsor: Mochida Pharmaceutical Company, Ltd. | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED